US Stock MarketDetailed Quotes

ORKA Oruka Therapeutics

Watchlist

20.260
+1.570+8.40%

Close Nov 27 16:00 ET

19.250
-1.010-4.99%

Post 20:01 ET

709.07MMarket Cap-53315P/E (TTM)

Oruka Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Assets

Current assets

Cash, cash equivalents and short term investments

--410.88M

--15.12M

--27.74M

-Cash and cash equivalents

--410.88M

--15.12M

--27.74M

Receivables

--0

Prepaid assets

----

--1.43M

----

Other current assets

--2.07M

--275K

----

Total current assets

--412.95M

--16.82M

--27.74M

Non current assets

Net PPE

--1.1M

--999K

----

-Gross PPE

--1.1M

--999K

----

Other non current assets

--43K

--2.36M

--488K

Total non current assets

--1.14M

--3.36M

--488K

Total assets

--414.09M

--20.18M

--28.23M

Liabilities

Current liabilities

Payables

--8.5M

--18.02M

--5.9M

-accounts payable

--8.5M

--2.58M

--5.9M

-Due to related parties current

----

--15.44M

----

Current accrued expenses

--777K

--795K

--1.13M

Current debt and capital lease obligation

--146K

--61K

----

-Current capital lease obligation

--146K

--61K

----

Other current liabilities

--7.68M

--430K

--56K

Current liabilities

--18.04M

--19.36M

--7.17M

Non current liabilities

Long term debt and capital lease obligation

--842K

--25.91M

--24.98M

-Long term debt

----

--24.98M

-Long term capital lease obligation

--842K

--925K

----

Non current accrued expenses

----

--961K

--214K

Preferred securities outside stock equity

--52.84M

--2.93M

Total non current liabilities

--53.68M

--29.8M

--28.13M

Total liabilities

--71.72M

--49.16M

--35.29M

Shareholders'equity

Share capital

--2.97M

--0

--1K

-common stock

--35K

--0

--1K

-Preferred stock

--2.93M

----

Retained earnings

---57.94M

---29.32M

---7.08M

Paid-in capital

--397.35M

--339K

--17K

Total stockholders'equity

--342.37M

---28.98M

---7.06M

Total equity

--342.37M

---28.98M

---7.06M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments	--410.88M	--15.12M	--27.74M
-Cash and cash equivalents	--410.88M	--15.12M	--27.74M
Receivables	--0	--0	--0
Prepaid assets	----	--1.43M	----
Other current assets	--2.07M	--275K	----
Total current assets	--412.95M	--16.82M	--27.74M
Non current assets
Net PPE	--1.1M	--999K	----
-Gross PPE	--1.1M	--999K	----
Other non current assets	--43K	--2.36M	--488K
Total non current assets	--1.14M	--3.36M	--488K
Total assets	--414.09M	--20.18M	--28.23M
Liabilities
Current liabilities
Payables	--8.5M	--18.02M	--5.9M
-accounts payable	--8.5M	--2.58M	--5.9M
-Due to related parties current	----	--15.44M	----
Current accrued expenses	--777K	--795K	--1.13M
Current debt and capital lease obligation	--146K	--61K	----
-Current capital lease obligation	--146K	--61K	----
Other current liabilities	--7.68M	--430K	--56K
Current liabilities	--18.04M	--19.36M	--7.17M
Non current liabilities
Long term debt and capital lease obligation	--842K	--25.91M	--24.98M
-Long term debt	----	--24.98M	--24.98M
-Long term capital lease obligation	--842K	--925K	----
Non current accrued expenses	----	--961K	--214K
Preferred securities outside stock equity	--52.84M	--2.93M	--2.93M
Total non current liabilities	--53.68M	--29.8M	--28.13M
Total liabilities	--71.72M	--49.16M	--35.29M
Shareholders'equity
Share capital	--2.97M	--0	--1K
-common stock	--35K	--0	--1K
-Preferred stock	--2.93M	----	----
Retained earnings	---57.94M	---29.32M	---7.08M
Paid-in capital	--397.35M	--339K	--17K
Total stockholders'equity	--342.37M	---28.98M	---7.06M
Total equity	--342.37M	---28.98M	---7.06M
Currency Unit	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data